Novartis (NVS) stock is in focus as the company partners with Unnatural Products in a deal worth up to $1.8B to develop oral ...

"Our vision is to turn the world's most powerful photosynthetic cell into a platform for scalable drug production that could ...

Drug development and production rely on stringent quality controls, reproducibility, and verification. Biopharmaceuticals, including protein-based therapies, require extensive characterization, ...

Under the agreement, UNP will receive up to $100m in upfront and pre-IND milestone payments.

Peptides are short chains of amino acids, which differ from proteins due to their short length and can include two or more amino acids. 3 Protein-protein interactions underlie many critical cellular ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that it has selected ASC36 oral tablets, its first oral amylin receptor peptide agonist, for clinical development. Ascletis expects to submit an ...

Lasso peptides are natural products made by bacteria. Their unusual lasso shape endows them with remarkable stability, protecting them from extreme conditions. In a new study, published in Nature ...

- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than ...

Peptide therapy consists of a unique pharmaceutical class of agents that are constructed of a range of organized amino acids.